The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 07, 2023
Filed:
Apr. 21, 2021
Applicant:
Universidade Estadual DE Campinas—unicamp, Campinas, BR;
Inventors:
Wagner José Favaro, Campinas, BR;
Nelson Eduardo Duran Caballero, Paulinia, BR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C01C 1/02 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61K 39/39 (2006.01); C01B 25/02 (2006.01); C01F 5/32 (2006.01); A61K 38/00 (2006.01); B82Y 5/00 (2011.01); B82Y 40/00 (2011.01);
U.S. Cl.
CPC ...
C01C 1/026 (2013.01); A61K 39/39 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C01B 25/02 (2013.01); C01F 5/32 (2013.01); A61K 38/00 (2013.01); B82Y 5/00 (2013.01); B82Y 40/00 (2013.01);
Abstract
Disclosed is a method of obtaining a protein-associated nanostructured complex (MRB-CFI-1) by chemical synthesis and antitumor use. The main use is in treating cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.